Amylyx Pharmaceuticals Ownership | Who Owns Amylyx Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Amylyx Pharmaceuticals Ownership Summary

Amylyx Pharmaceuticals is owned by 64.30% institutional investors, 14.32% insiders, and 21.38% retail investors. Vanguard group is the largest institutional shareholder, holding 6.23% of AMLX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.64% of its assets in Amylyx Pharmaceuticals shares.

AMLX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Amylyx Pharmaceuticals	64.30%	14.32%	21.38%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	4.22M	6.23%	$8.03M
Aqr capital management	3.34M	4.92%	$6.35M
Blackrock	2.67M	3.93%	$5.07M
Goldman sachs group	2.61M	3.85%	$4.96M
Almitas capital	1.90M	2.81%	$3.62M
Alyeska investment group	1.82M	2.69%	$3.46M
683 capital management	1.50M	2.21%	$2.85M
D. e. shaw	1.31M	1.93%	$2.49M
Two sigma investments, lp	1.30M	1.91%	$2.47M
Acadian asset management	1.21M	1.79%	$2.30M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Almitas capital	1.90M	1.50%	$3.62M
Aldebaran capital	269.80K	0.48%	$512.63K
683 capital management	1.50M	0.22%	$2.85M
Xtx topco	210.61K	0.03%	$400.16K
Point72 asia (singapore) pte.	82.04K	0.03%	$155.88K
Alyeska investment group	1.82M	0.02%	$3.46M
Tang capital management	100.00K	0.02%	$190.00K
State of wyoming	61.78K	0.02%	$117.39K
Graham capital management	321.87K	0.01%	$611.55K
Hennion & walsh asset management	118.98K	0.01%	$226.07K

Top Buyers

Holder	Shares	% Assets	Change
Aqr capital management	3.34M	0.01%	3.22M
Almitas capital	1.90M	1.50%	1.90M
683 capital management	1.50M	0.22%	1.50M
Acadian asset management	1.21M	0.01%	1.21M
Alyeska investment group	1.82M	0.02%	814.81K

Top Sellers

Holder	Shares	% Assets	Change
State street	154.91K	-	-1.91M
Franklin resources	-	-	-1.86M
Blackrock	2.67M	0.00%	-1.80M
Boxer capital	-	-	-1.50M
Morgan stanley	924.46K	0.00%	-1.15M

New Positions

Holder	Shares	% Assets	Change	Value
Almitas capital	1.90M	1.50%	1.90M	$3.62M
683 capital management	1.50M	0.22%	1.50M	$2.85M
Acadian asset management	1.21M	0.01%	1.21M	$2.30M
Jacobs levy equity management	589.11K	0.00%	589.11K	$1.12M
Aldebaran capital	269.80K	0.48%	269.80K	$512.63K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-10.00
Kelly financial services	-33.00
Gamma investing	-35.00
Redwood wealth management group	-200.00
Fernwood investment management	-200.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	127	-28.25%	43,627,452	-12.05%	64	1.19%	58	-33.33%	47	-2.08%
Mar 31, 2024	177	-14.08%	49,605,091	-17.71%	73	0.92%	87	-25.64%	48	-4.00%
Dec 31, 2023	206	8.99%	60,281,733	2.30%	89	1.16%	117	10.38%	50	2.04%
Sep 30, 2023	189	11.18%	58,927,724	8.03%	87	1.31%	106	11.58%	49	6.52%
Jun 30, 2023	170	3.66%	54,545,075	6.17%	81	1.38%	95	-6.86%	46	21.05%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.81M	2.64%	-
abrdn Healthcare Investors	1.37M	2.00%	-
Vanguard Small Cap Index	646.02K	0.95%	1.52K
Vanguard Institutional Extnd Mkt Idx Tr	600.39K	0.88%	-
abrdn Life Sciences Investors	603.75K	0.88%	-
Jupiter Merian Glb Eq AbsRet I USD Acc	480.21K	0.71%	185.87K
Vanguard Small Cap Growth Index Inv	357.96K	0.53%	-1.58K
Vanguard Strategic Small-Cap Equity Inv	348.38K	0.51%	-
Schwab Small-Cap Equity	331.23K	0.49%	240.56K
Fidelity Extended Market Index	300.83K	0.44%	110.69K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 30, 2024	Klee Justin B.	Co-Chief Executive Officer	Sell	$59.43K
Sep 30, 2024	Cohen Joshua B	Co-Chief Executive Officer	Sell	$59.41K
Sep 30, 2024	Bedrosian Camille L	Chief Medical Officer	Sell	$36.56K
Sep 30, 2024	Mazzariello Gina	Chief Legal Officer	Sell	$27.84K
Sep 12, 2024	FRATES JAMES M	Chief Financial Officer	Buy	$101.37K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q3	3	4
2024 Q2	2	1
2024 Q1	-	9
2023 Q4	1	-

AMLX Ownership FAQ

Who Owns Amylyx Pharmaceuticals?

Amylyx Pharmaceuticals shareholders are primarily institutional investors at 64.30%, followed by 14.32% insiders and 21.38% retail investors. The average institutional ownership in Amylyx Pharmaceuticals's industry, Biotech Stocks , is 44.97%, which Amylyx Pharmaceuticals exceeds.

Who owns the most shares of Amylyx Pharmaceuticals?

Amylyx Pharmaceuticals’s largest shareholders are Vanguard group (4.22M shares, 6.23%), Aqr capital management (3.34M shares, 4.92%), and Blackrock (2.67M shares, 3.93%). Together, they hold 15.08% of Amylyx Pharmaceuticals’s total shares outstanding.

Does Blackrock own Amylyx Pharmaceuticals?

Yes, BlackRock owns 3.93% of Amylyx Pharmaceuticals, totaling 2.67M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 5.07M$. In the last quarter, BlackRock decreased its holdings by -1.805M shares, a -40.34% change.

Who is Amylyx Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Almitas capital is Amylyx Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 1.50% of its assets in 1.9M Amylyx Pharmaceuticals shares, valued at 3.62M$.

Who is the top mutual fund holder of Amylyx Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Amylyx Pharmaceuticals shares, with 2.64% of its total shares outstanding invested in 1.81M Amylyx Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools